Newborn Screening for Metachromatic Leukodystrophy: Care Pathway and Early Clinical Outcomes from German and Austrian Pilot Programs
Lucia Laugwitz(University Children's Hospital Tübingen), Samuel Groeschel(University of Tübingen), Ursula Holzer(University Children's Hospital Tübingen), Nils Janzen(Medizinische Hochschule Hannover), Sebastian Graeter(University Children's Hospital Tübingen), Petra Oliva, Pascal Martin(Hertie Institute for Clinical Brain Research), Maximilian Zeyda(Medical University of Vienna), Daniela Karall(Innsbruck Medical University), Stefanie Beck‐Woedl(University of Tübingen), Sebastian Hegert(Screen), Barbara Plecko(Graz University Hospital), Nadja Kaiser(University Children's Hospital Tübingen), T. B. Haack(University Children's Hospital Tübingen), Christiane Kehrer(University Children's Hospital Tübingen), H Rosewich(University Children's Hospital Tübingen), Jan Kern(University Children's Hospital Tübingen), Peter Lang(University Children's Hospital Tübingen), Lukas Neubauer(Medical University of Graz), Thomas Zöggeler(Innsbruck Medical University), Stephan T. Hold, Vassiliki Konstantopoulou(Medical University of Vienna), Tom Launer(University Children's Hospital Tübingen), Thomas Neiße(Screen), Annina-Clarissa Jaeger(University Children's Hospital Tübingen), Philipp Juengling(University Children's Hospital Tübingen), Tim Flaadt(University Children's Hospital Tübingen), David Kasper, Madeleine Wacker(University Children's Hospital Tübingen)
Cited by 0
Related Papers
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
|Brain|2017|546
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation
|Journal of Inherited Metabolic Disease|2015|248
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype
|Journal of Inherited Metabolic Disease|2015|236
Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
|American Journal of Clinical Nutrition|2012|227